PROSPECTIVE-STUDY OF STROMELYSIN-3 EXPRESSION IN BREAST-CANCER BIOPSIES AND DISEASE-FREE SURVIVAL

  • Authors:
    • R HAHNEL
  • View Affiliations

  • Published online on: December 1, 1995     https://doi.org/10.3892/ijo.7.6.1315
  • Pages: 1315-1318
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Stromelysin-3 was estimated by Northern blot analysis in primary breast carcinomas. The patients were followed for an average of 47 months after initial surgery and the dates of recurrent carcinoma and of death, if applicable, were recorded. Stromelysin-3 expression in the primary tumour was found equally in patients with subsequent recurrent disease and in patients who remained disease-free during the study period. There was no correlation between stromelysin-3 levels and disease-free survival.

Related Articles

Journal Cover

December 1995
Volume 7 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
HAHNEL, R. (1995). PROSPECTIVE-STUDY OF STROMELYSIN-3 EXPRESSION IN BREAST-CANCER BIOPSIES AND DISEASE-FREE SURVIVAL. International Journal of Oncology, 7, 1315-1318. https://doi.org/10.3892/ijo.7.6.1315
MLA
HAHNEL, R."PROSPECTIVE-STUDY OF STROMELYSIN-3 EXPRESSION IN BREAST-CANCER BIOPSIES AND DISEASE-FREE SURVIVAL". International Journal of Oncology 7.6 (1995): 1315-1318.
Chicago
HAHNEL, R."PROSPECTIVE-STUDY OF STROMELYSIN-3 EXPRESSION IN BREAST-CANCER BIOPSIES AND DISEASE-FREE SURVIVAL". International Journal of Oncology 7, no. 6 (1995): 1315-1318. https://doi.org/10.3892/ijo.7.6.1315